Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

Similar articles for PubMed (Select 18728788)

1.

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties.

Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE.

PLoS One. 2008 Aug 27;3(8):e3077. doi: 10.1371/journal.pone.0003077.

2.

Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.

Azzi S, Bruno S, Giron-Michel J, Clay D, Devocelle A, Croce M, Ferrini S, Chouaib S, Vazquez A, Charpentier B, Camussi G, Azzarone B, Eid P.

J Natl Cancer Inst. 2011 Dec 21;103(24):1884-98. doi: 10.1093/jnci/djr451. Epub 2011 Oct 31.

3.

Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop.

Levina V, Marrangoni A, Wang T, Parikh S, Su Y, Herberman R, Lokshin A, Gorelik E.

Cancer Res. 2010 Jan 1;70(1):338-46. doi: 10.1158/0008-5472.CAN-09-1102. Epub 2009 Dec 22.

4.

Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.

Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.

Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.

5.

Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.

Ma L, Lai D, Liu T, Cheng W, Guo L.

Acta Biochim Biophys Sin (Shanghai). 2010 Sep;42(9):593-602. doi: 10.1093/abbs/gmq067. Epub 2010 Aug 12.

PMID:
20705681
6.

Lung cancer stem cells as a target for therapy.

Gorelik E, Lokshin A, Levina V.

Anticancer Agents Med Chem. 2010 Feb;10(2):164-71. Review.

PMID:
20184538
7.

Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY.

Gastroenterology. 2007 Jun;132(7):2542-56. Epub 2007 Apr 15.

PMID:
17570225
8.

Anticancer effects of cinnamic acid in lung adenocarcinoma cell line h1299-derived stem-like cells.

Huang Y, Zeng F, Xu L, Zhou J, Liu X, Le H.

Oncol Res. 2013;20(11):499-507. doi: 10.3727/096504013X13685487925095.

PMID:
24063280
9.

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.

Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U, Sozzi G.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16281-6. doi: 10.1073/pnas.0905653106. Epub 2009 Sep 10.

10.

CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).

Choijamts B, Jimi S, Kondo T, Naganuma Y, Matsumoto T, Kuroki M, Iwasaki H, Emoto M.

Stem Cells. 2011 Oct;29(10):1485-95. doi: 10.1002/stem.711.

11.

Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.

Gambelli F, Sasdelli F, Manini I, Gambarana C, Oliveri G, Miracco C, Sorrentino V.

Cell Biol Int. 2012 Jan;36(1):29-38. doi: 10.1042/CBI20110013.

PMID:
21916848
12.

Chemotherapeutic drugs and human tumor cells cytokine network.

Levina V, Su Y, Nolen B, Liu X, Gordin Y, Lee M, Lokshin A, Gorelik E.

Int J Cancer. 2008 Nov 1;123(9):2031-40. doi: 10.1002/ijc.23732.

13.

Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.

Kubo T, Takigawa N, Osawa M, Harada D, Ninomiya T, Ochi N, Ichihara E, Yamane H, Tanimoto M, Kiura K.

Cancer Sci. 2013 Jan;104(1):78-84. doi: 10.1111/cas.12045. Epub 2012 Nov 24.

PMID:
23066953
14.

Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.

Navarro-Alvarez N, Kondo E, Kawamoto H, Hassan W, Yuasa T, Kubota Y, Seita M, Nakahara H, Hayashi T, Nishikawa Y, Hassan RA, Javed SM, Noguchi H, Matsumoto S, Nakaji S, Tanaka N, Kobayashi N, Soto-Gutierrez A.

Cell Transplant. 2010;19(6):865-77. doi: 10.3727/096368910X508997. Epub 2010 Jun 29.

15.

Isolation of cancer stem cells from transformed human mesenchymal stem cell line F6.

Xu X, Qian H, Zhu W, Zhang X, Yan Y, Wang M, Xu W.

J Mol Med (Berl). 2010 Nov;88(11):1181-90. doi: 10.1007/s00109-010-0659-5. Epub 2010 Aug 10.

PMID:
20697686
16.

New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.

Botchkina GI, Zuniga ES, Das M, Wang Y, Wang H, Zhu S, Savitt AG, Rowehl RA, Leyfman Y, Ju J, Shroyer K, Ojima I.

Mol Cancer. 2010 Jul 14;9:192. doi: 10.1186/1476-4598-9-192.

17.

Identification of a cancer stem-like population in the Lewis lung cancer cell line.

Zhang AM, Fan Y, Yao Q, Ma H, Lin S, Zhu CH, Wang XX, Liu J, Zhu B, Sun JG, Chen ZT.

Asian Pac J Cancer Prev. 2012;13(3):761-6.

18.

In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.

Wei XD, Zhou L, Cheng L, Tian J, Jiang JJ, Maccallum J.

Head Neck. 2009 Jan;31(1):94-101. doi: 10.1002/hed.20935.

PMID:
18853445
19.

CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics.

Nian WQ, Chen FL, Ao XJ, Chen ZT.

Mol Cell Biochem. 2011 Sep;355(1-2):241-8. doi: 10.1007/s11010-011-0860-z. Epub 2011 May 7.

PMID:
21553023
20.

Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.

Chiou GY, Cherng JY, Hsu HS, Wang ML, Tsai CM, Lu KH, Chien Y, Hung SC, Chen YW, Wong CI, Tseng LM, Huang PI, Yu CC, Hsu WH, Chiou SH.

J Control Release. 2012 Apr 30;159(2):240-50. doi: 10.1016/j.jconrel.2012.01.014. Epub 2012 Jan 21.

PMID:
22285547
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk